Reliability and Validity of the Boston Bedside Quantitative Sensory Testing Battery for Neuropathic Pain
- PMID: 32895703
- PMCID: PMC7593797
- DOI: 10.1093/pm/pnaa192
Reliability and Validity of the Boston Bedside Quantitative Sensory Testing Battery for Neuropathic Pain
Abstract
Objective: Recent studies suggest that sensory phenotyping may provide critical information for the diagnosis and management of patients with chronic neuropathic pain (NP). However, many formal quantitative sensory testing (QST) paradigms require expensive equipment, a dedicated location, and substantial time commitments on the part of patient and examiner, highlighting the need for a convenient and portable "bedside" QST battery. We developed and tested a bedside QST battery in a sample of patients with chronic NP.
Methods: Participants (N = 51) attended two in-person visits over approximately two weeks, during which they underwent QST using both laboratory-based equipment and simple, easily accessible bedside tools. Participants also completed questionnaires about their daily pain and NP symptoms.
Results: Test-retest reliability estimates were highly statistically significant and did not differ between bedside (mean r = 0.60) and laboratory-based (mean r = 0.72) QST. Bedside QST variables and corresponding laboratory-based QST variables were highly correlated, suggesting adequate criterion validity for the bedside tests.
Conclusions: Results from the present study may have important implications for the sensory phenotyping and subsequent management of patients with chronic NP. Implementation of a protocol that uses inexpensive, portable, and convenient tools may allow for the application of QST in variety of clinical settings and advance NP research.
Keywords: Neuropathic; Pain; Quantitative Sensory Testing.
© The Author(s) 2020. Published by Oxford University Press on behalf of the American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures





Similar articles
-
Test-retest reliability of a simple bedside-quantitative sensory testing battery for chronic neuropathic pain.Pain Rep. 2023 Jan 13;8(1):e1049. doi: 10.1097/PR9.0000000000001049. eCollection 2023 Jan. Pain Rep. 2023. PMID: 36660554 Free PMC article.
-
Test-Retest and Inter-Examiner Reliability of a Novel Bedside Quantitative Sensory Testing Battery in Postherpetic Neuralgia Patients.J Pain. 2020 Jul-Aug;21(7-8):858-868. doi: 10.1016/j.jpain.2019.11.013. Epub 2019 Dec 11. J Pain. 2020. PMID: 31837446 Free PMC article.
-
Test-retest and interobserver reliability of quantitative sensory testing according to the protocol of the German Research Network on Neuropathic Pain (DFNS): a multi-centre study.Pain. 2011 Mar;152(3):548-556. doi: 10.1016/j.pain.2010.11.013. Epub 2011 Jan 14. Pain. 2011. PMID: 21237569
-
[Quantitative sensory testing for neuropathic pain and its relevance for physiotherapy].Schmerz. 2022 Dec;36(6):437-446. doi: 10.1007/s00482-021-00576-z. Epub 2021 Aug 23. Schmerz. 2022. PMID: 34424391 Free PMC article. Review. German.
-
Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities.Clin J Pain. 2009 Sep;25(7):641-7. doi: 10.1097/AJP.0b013e3181a68c7e. Clin J Pain. 2009. PMID: 19692807 Review.
Cited by
-
Biofeedback EMG alternative therapy for chronic low back pain (the BEAT-pain study).Digit Health. 2023 Feb 7;9:20552076231154386. doi: 10.1177/20552076231154386. eCollection 2023 Jan-Dec. Digit Health. 2023. PMID: 36776410 Free PMC article.
-
Introducing a revised version of the Kumamoto scale as an easy-to-use clinical tool for monitoring multisystemic changes in hereditary transthyretin amyloidosis.Orphanet J Rare Dis. 2025 Jul 25;20(1):377. doi: 10.1186/s13023-025-03915-w. Orphanet J Rare Dis. 2025. PMID: 40713704 Free PMC article.
-
Reliability of a clinical sensory test battery in patients with spine-related leg and arm pain.Eur J Pain. 2024 Sep;28(8):1366-1377. doi: 10.1002/ejp.2267. Epub 2024 Mar 25. Eur J Pain. 2024. PMID: 38525884 Free PMC article.
-
Activity-related pain and sensitization predict within- and between-person pain experience in people with knee osteoarthritis: An ecological momentary assessment study.Osteoarthr Cartil Open. 2024 Feb 10;6(1):100439. doi: 10.1016/j.ocarto.2024.100439. eCollection 2024 Mar. Osteoarthr Cartil Open. 2024. PMID: 38384978 Free PMC article.
-
Brief Assessment of Patient Phenotype to Explain Variability in Postsurgical Pain and Opioid Consumption after Cesarean Delivery: Performance of a Novel Brief Questionnaire Compared to Long Questionnaires.Anesthesiology. 2024 Apr 1;140(4):701-714. doi: 10.1097/ALN.0000000000004900. Anesthesiology. 2024. PMID: 38207329 Free PMC article.
References
-
- Jensen TS, Baron R, Haanpää M, et al.A new definition of neuropathic pain. Pain 2011;152(10):2204–5. - PubMed
-
- Van Hecke O, Austin SK, Khan RA, et al. Neuropathic pain in the general population: A systematic review of epidemiological studies. Pain 2014;155(4):654–62. - PubMed
-
- Smith BH, Torrance N.. Epidemiology of neuropathic pain and its impact on quality of life. Curr Pain Headache Rep 2012;16(3):191–8. - PubMed
-
- Dworkin RH, O'Connor AB, Backonja M, et al.Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain 2007;132(3):237–51. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous